Skip to main content

Table 4 Quality assessment of cohort studies

From: Effect of arsenic on the risk of gestational diabetes mellitus: a systematic review and meta-analysis

First authors

Year

Country

Study type

Selection

Comparability

Outcome

Total score

Quality

A

B

C

D

E

F

J

H

Shapiro

2015

Canada

Cohort study

1

1

1

1

1

1

0

0

6

Moderate

Ashley-Martin

2018

Canada

Cohort study

1

1

1

1

1

1

0

0

6

Moderate

Xia

2018

China

Cohort study

1

1

1

1

1

1

0

1

7

High

Wang

2019

China

Cohort study

1

1

1

1

1

1

0

0

6

Moderate

Wang

2020

China

Cohort study

1

1

1

1

1

1

0

1

7

High

  1. A: Representativeness of the exposed cohort (0/1 point); B: Selection of the nonexposed cohort (0/1 point); C: Ascertainment of exposure (0/1 point); D: Demonstration that outcome of interest was not present at the start of the study (0/1 point); E: Comparability of cohorts based on the design or analysis (0/1/2 point); F: Assessment of outcome (0/1 point); G: Was follow-up long enough for outcomes to occur (0/1 point); H: Adequacy of follow-up of cohorts (0/1 point)